Evidence map›Paper›PMID 33251156›Full record

ArticleFrontiers in cellular and infection microbiology2020

Betulinic Acid Exerts Cytoprotective Activity on Zika Virus-Infected Neural Progenitor Cells.

Bruno R R Cavalcante, Luciana S Aragão-França, Gabriela L A Sampaio, Carolina K V Nonaka, Moisés S Oliveira, Gúbio S Campos, Silvia I Sardi, Beatriz R S Dias, Juliana P B Menezes, Vinícius P C Rocha and 8 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Using 2D and 3D pluripotent stem cell models to study neurotropic viruses.Frontiers in virology (Lausanne, Switzerland) · 2022
    Article
  17. Type I interferon receptor (Frontiers in immunology · 2022
    Article
  18. Review
  19. Zika Virus: A New Therapeutic Candidate for Glioblastoma Treatment.International journal of molecular sciences · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Bruno R R CavalcanteCenter for Biotechnology and Cell Therapy, São Rafael Hospital, Salvador, Brazil.
Luciana S Aragão-FrançaCenter for Biotechnology and Cell Therapy, São Rafael Hospital, Salvador, Brazil.
Gabriela L A SampaioCenter for Biotechnology and Cell Therapy, São Rafael Hospital, Salvador, Brazil.
Carolina K V NonakaCenter for Biotechnology and Cell Therapy, São Rafael Hospital, Salvador, Brazil.
Moisés S OliveiraGonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Brazil.
Gúbio S CamposInstitute of Health Sciences, Federal University of Bahia, Salvador, Brazil.
Silvia I SardiInstitute of Health Sciences, Federal University of Bahia, Salvador, Brazil.
Beatriz R S DiasGonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Brazil.
Juliana P B MenezesGonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Brazil.
Vinícius P C RochaGonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Brazil.
Erik A RossiGonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Brazil.
Bruno D ParedesCenter for Biotechnology and Cell Therapy, São Rafael Hospital, Salvador, Brazil.
Gabriele L S MartinsGonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Brazil.
Kyan J AllahdadiCenter for Biotechnology and Cell Therapy, São Rafael Hospital, Salvador, Brazil.
Laisla R PeixotoDepartment of Pharmacy, Federal University of Paraíba, João Pessoa, Brazil.
José M Barbosa-FilhoDepartment of Pharmacy, Federal University of Paraíba, João Pessoa, Brazil.
Bruno S F SouzaCenter for Biotechnology and Cell Therapy, São Rafael Hospital, Salvador, Brazil.
Milena B P SoaresGonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Brazil.
Fundação Oswaldo Cruz · BRD’Or Institute for Research and Education · BRHospital São Rafael · BRUniversidade Federal da Bahia · BRUniversidade Federal da Paraíba · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zika virus (ZIKV), a member of the Flaviviridae family, was brought into the spotlight due to its widespread and increased pathogenicity, including Guillain-Barré syndrome and microcephaly. Neural progenitor cells (NPCs), which are multipotent cells capable of differentiating into the major neural phenotypes, are very susceptible to ZIKV infection. Given the complications of ZIKV infection and potential harm to public health, effective treatment options are urgently needed. Betulinic acid (BA), an abundant terpenoid of the lupane group, displays several biological activities, including neuroprotective effects. Here we demonstrate that Sox2

Indexed as

MicrocephalyNeural Stem CellsZika VirusZika Virus InfectionBetulinic AcidHumansPentacyclic TriterpenesBetulinic AcidPentacyclic Triterpenesapoptosisbetulinic acidneural progenitor cellsneuroprotectionZika virus

Identifiers

PMID33251156
PMCPMC7674920
OpenAlexW3095271748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.